EMA Authorised: Lacosamide UCB (lacosamide) — UCB Pharma S.A.

View source ↗

Summary

EMA authorises lacosamide (Lacosamide UCB) for partial epilepsies in EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Drugs mentioned

• Lacosamide UCB (lacosamide)

Snippet

Status: Authorised. Therapeutic area: Epilepsies, Partial. MAH: UCB Pharma S.A.. Decision date: 23/07/2026